2023
Movva N , Pastula ST , Rege SV, Lewis RJ, Bylsma LC . 2023. Scoping review of employer-led research using employee health claims data. Popul Health Manag 26(5):341-352; doi: 10.1089/pop.2023.0140 . PMID: 37682577.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Dalvi T, Nørgaard M, Fryzek JP, Movva N , Pedersen L, Hansen HP, et al. 2023. Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark. PLoS ONE 18(4):e0284037; doi: 10.1371/journal.pone.0284037 . PMID: 37040387.
View Abstract
Topics: Cancer , Epidemiology
Bullano M, Cool C, Schultz BG, Durgapal S, Sacks N , Liu Y , Kee R, Batt K. 2023. Evaluating the financial impact of utilizing recombinant porcine factor VIII or recombinant FVIIa for patients with acquired hemophilia A. Expert Rev Phamacoecon Outcome Res 23(2):225-230; doi: 10.1080/14737167.2023.2160705 . PMID: 36537696.
View Abstract
Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
2022
Doepker C, Movva N, Cohen SS, Wikoff DS. 2022. Benefit-risk of coffee consumption and all-cause mortality: A systematic review and disability adjusted life year analysis. Food Chem Toxicol 170(Dec):113472; doi: 10.1016/j.fct.2022.113472 . PMID: 36243217.
View Abstract
Topics: Food science , Systematic Review , Toxicology
Broome CM, Hooda N , Su J, Jiang X , Nicholson G, Frankenfeld CL , Iglesias-Rodriguez M, Fryzek J, Patel Parija. 2022. Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States. PLoS One 17(12):e0276617; doi: 10.1371/journal.pone.0276617 . PMID: 36520848.
View Abstract
Topics: Epidemiology
Cardosi L, Rau R, Emdem MR, Kemp R, Minshall M, Pontenani F, Provision S, Sacks N . 2022. Healthcare resource utilization in non-cystic fibrosis bronchiectasis (NCFB) patients with commercial insurance coverage in the US. Value in Health 25(12):S89-S90; doi: 10.1016/j.jval.2022.09.437 .
View Abstract
Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Yao W, Jensen I , Claussen M, Dandurand K, Buffington B, Fuentes D, Mikhael M. 2022. Health economics of selective early rescue surfactant administration and standard surfactant administration for newborns with respiratory distress syndrome. J Pediatr Pharmacol Ther 27(8):695–702; doi: 10.5863/1551-6776-27.8.695 .
View Abstract
Topics: cost-consequence , cost-utility analysis , Health Economics and Outcomes Research (HEOR) , respiratory distress syndrome
Cohen SS, Bylsma LC, Movva N , Alexander DD. 2022. Theoretical attributable risk analysis and Disability Adjusted Life Years (DALYs) based on increased dairy consumption. BMC Public Health 22(1):1625; doi: 10.1186/s12889-022-14042-7 . PMID: 36030208.
View Abstract
Topics: Epidemiology , Food science , risk assessment , Toxicology
Danese MD, Schenfeld J, Shaw J, Gawade P, Balasubramanian A, Kelsh M , et al. 2022. Association between granulocyte colony-stimulating factor (G-CSF) use and myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) among elderly patients with breast, lung, or prostate cancer. Adv Ther 39(6):2778–2795; doi:10.1007/s12325-022-02141-1 . PMID: 35430673.
View Abstract
Topics: Cancer , Epidemiology
Schenfeld J, Gong T, Henry D, Kelsh M , Gawade P, Peng Y, Bradbury BD, Li S. 2022. Patterns of primary prophylactic granulocyte colony-stimulating factor use in older Medicare patients with cancer receiving myelosuppressive chemotherapy. Support Care Cancer 30(7):6327–6338; doi: 10.1007/s00520-022-06967-x . PMID: 35482126.
View Abstract
A Division of